In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, the Director of the Office of Prescription Drug Promotion (OPDP) at the ...

Improved loss from operations by 31% - - Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health ...

Evofem Biosciences, Inc. ( (EVFM) ) has released its Q3 earnings. Here is a breakdown of the information Evofem Biosciences, Inc. presented to ...

Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced financial results ...

The New Home Company today announced that the Company will release its financial results for the fiscal 2024 fourth quarter on its confidential data site on Wednesday, November 20, 2024. The Company ...

Aditxt (NASDAQ: ADTX) announced today that its Acquisition target, Evofem Biosciences, Inc. (OTCQB: EVFM), has secured voting agreements from key investors, solidifying their commitment to vote in ...

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, announced today that its acquisition target, Evofem ...

Evofem Biosciences, Inc. ("Evofem" or the "Company") today announced it has secured voting agreements with certain of its Series E-1 stockholders and convertible noteholders to ensure they will vote ...

Evofem Biosciences ( (EVFM) ) has provided an announcement. Evofem Biosciences has secured pivotal voting agreements from its Series E-1 ...

Evofem Biosciences, Inc. (OTCQB:OTC:EVFM), a pharmaceutical company, has entered into support agreements with several institutional investors as part of its ongoing merger process with Aditxt ...

Evofem Biosciences ( (EVFM)) has issued an announcement. Evofem Biosciences, Inc. has entered into support agreements with institutional investors to facilitate its merger with Aditxt, Inc ...

Evofem Biosciences, Inc. (OTCQB:OTC:EVFM), a pharmaceutical company, has entered into support agreements with several institutional investors as part of its ongoing merger process with Aditxt, Inc.